We found that the ctDNA concentration in patients with BRAF-mutated urothelial carcinoma is increased compared to that in wild-type patients, demonstrating that the BRAF mutation in urothelial carcinoma may be detectable in the plasma of these canines. The gene discussed is BRAF; the disease is urothelial carcinoma.